Cleared Traditional

ENSEAL X1 Tissue Sealer, Curved Jaw, Articulating 37 cm Shaft Length (K180403) - FDA 510(k) Clearance

Also marketed or referenced as:
ENSEAL X1 Tissue Sealer, Curved Jaw, Articulating 45 cm Shaft Length

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K180403 · Ethicon Endo-Surgery, LLC · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2018
Decision
98d
Days
Class 2
Risk

K180403 is an FDA 510(k) clearance for the ENSEAL X1 Tissue Sealer, Curved Jaw, Articulating 37 cm Shaft Length. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Ethicon Endo-Surgery, LLC (Guaynabo, US). The FDA issued a Cleared decision on May 23, 2018 after a review of 98 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Ethicon Endo-Surgery, LLC devices

Submission Details

510(k) Number K180403 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 14, 2018
Decision Date May 23, 2018
Days to Decision 98 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 115d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Ethicon Endo-Surgery, Inc.
Kweku Biney

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 787
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K180403.
Valleylab FT10 Energy Platform, Valleylab FX8 FX Series Energy Platform
K181389 · Covidien · Jun 2018
Pollogen Legend System
K173503 · Pollogen, Ltd. · Jun 2018
InMode System with Fractora3D/3D-90 Applicators
K180189 · Inmode MD , Ltd. · Jun 2018
DiLumen Endolumenal Interventional Scissors (DiLumen Is)
K173405 · Lumendi, LLC · May 2018
Irrigation Tubing Bipolar Cord Set
K180908 · New Deantronics Taiwan , Ltd. · May 2018
Endopath Electrosurgery Probe Plus II
K180031 · Ethicon Endo-Surgery, LLC · May 2018